HCR-188

· Helicore Biopharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HCR-188, covering 2025-11-26 to 2025-11-26. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-human Study of HCR-188 in Overweight or Obese Otherwise Healthy Volunteers Without Type 2 Diabetes [EARLY_Phase 1]

See pricing